On December 11th, the pulse medical production base was filled with festive gongs and drums, welcoming galloping lions. Relevant officials from the medical departments of Zhuhai City and High tech Zone, Academician Ge Junbo, and clinical experts gathered together to witness the launch of the new production base, marking a new stage of rapid development for pulse medical!
Zhao Shijian, Secretary of the Party Working Committee of the High tech Zone, Chai Hongliang, Deputy Director of the Zhuhai Health Bureau, Fu Zhi, Deputy Director of the Zhuhai Industry and Information Technology Bureau, Zhang Hanming, Member of the Party Working Committee and Deputy Director of the Management Committee of the High tech Zone, and Zhang Jinghua, Second level Researcher of the High tech Zone, attended the launch ceremony of the new base
。
Pulse Medical Production Base
At the ceremony, the leaders of the city and district highly praised the achievements of Pulse Medical, vigorously developing the medical industry, especially the high-end medical industry, in Zhuhai. In this regard, Pulse Medical has gradually become a banner of cardiovascular medical equipment in Zhuhai. At the same time, they also hope that Pulse Medical will continue to develop and strive, not only as the pulse of China, but also to go global and become the pulse of the world.
Chairman Ruan Chengmin, founder of Pulse Medical, delivered a welcome speech on behalf of Pulse Medical, thanking leaders at all levels in the city for their concern and support for Pulse and their strong assistance. In the eight years of growth of Pulse Medical, together with numerous cardiovascular disease experts, we have gradually explored the "medical engineering integration" model of industry university research integration, allowing the clinical experience of many industry experts to be transformed into clinical achievements, benefiting more patients. This is also the corporate responsibility of Pulse Medical to uphold the principle of "benefiting the hearts of the people".
Founder of Pulse Medical, Ruan Chengmin, Chairman
Dean Wang Yan of Xiamen University Affiliated Cardiovascular Hospital said that in recent years, Pulse Medical has developed innovative medical devices, from the previous left ventricular volume reducing umbrella to the recently registered left atrial appendage occluder by the national bureau. As a clinical research unit, we have participated in the technological breakthroughs of these two innovative devices and achieved good clinical results. This is the original intention of medical device manufacturers, constantly researching and developing innovative products. Pulse Medical is driven by originality, building its own production capacity, and becoming a high-tech enterprise integrating design, research and development, and production.
Dean Wang Yan of Xiamen University Affiliated Cardiovascular Hospital
Ge Junbo, academician of the Chinese Academy of Sciences, was connected to the launching ceremony through live video. Academician Ge stated that China has the highest number and scale of interventional treatment patients in the world, and compared to other disciplines, the development history of interventional disciplines is relatively late. Since the introduction of interventional therapy into China, almost all high-value equipment and consumables have relied entirely on imports. Until now, imported products still dominate in the cardiovascular field. How to promote the localization of high-end interventional devices and solve the bottleneck problem of expensive medical treatment for the general public is also an urgent issue that the country and the medical industry need to address. The domestic substitution of medical devices is the trend. In recent years, there have been more and more innovative products of domestically produced instruments, which may achieve overtaking in certain niche directions. Pulse Medical seizes the opportunity of this era and will definitely make some achievements in the process of localization and substitution.
Professor Huo Yong, a professor at Peking University First Hospital, chief expert in cardiology, and president of the World Association of Chinese Cardiovascular Physicians, congratulates the launch of the new production base for pulse medicine. He said that Pulse Medical has gone through eight years, and now not only is it able to continuously research and develop new products based on clinical needs, but its production base is also constantly expanding. This shows that in China's medical enterprises, Pulse Medical continues to cultivate its internal strength, and is constantly increasing its production and manufacturing. For domestic high-end medical devices, we also have the capital to compete with foreign enterprises. The official opening of the new R&D and production base for Pulse Medical continuously innovates our own original research products, opening up the spring of domestic innovative medical devices.
Director Xu Yawei, Director of the Department of Cardiology and Chief Medical Officer of Pulse Medical at Tongji University Affiliated Tenth People's Hospital, said that Tongji University Affiliated Tenth People's Hospital and Pulse Medical have been closely related for a long time. In 2014, the hospital and Pulse Medical jointly established a "Industry University Research Cooperation Base" and developed high-performance medical device products with independent intellectual property rights through the "deep integration of medicine and engineering" model. In September of this year, Pulse's first product, the Lefear left atrial appendage occluder system, also successfully obtained the Class III medical device registration certificate from the national bureau, which is a model of achievements under the "medical engineering integration" model.
Looking back on the past eight years, Pulse Medical has embarked on the path of "medical engineering integration", established the Tongji University School of Medicine Postdoctoral Innovation Practice Base, the Tongji University Affiliated Tenth People's Hospital Industry University Research Cooperation Base, and worked closely with top cardiovascular disease experts to deeply understand product advantages. The company has completed the registration of the "Lefear Left Heart Ear Occluder System", and its research products cover various fields of cardiovascular disease. Pulse Medical is taking solid steps and moving forward on the road of independent research and development.